Topadur
Treatments for diabetic foot ulcer;chronic wounds and scars and keloids
Topadur has raised €2.0M across 1 funding round from 2 investors, most recently a Series A round in Apr 2016. Based in Rheinfelden, Switzerland; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2016-04
latest 2016-04
Funding by year
EUR raised per yearTopadur — funding by year — interactive chart.
Data table
| Topadur — funding by year | |
|---|---|
| 2016 | €2.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-04-01 | Series A | €2.0M | EuroStars,The Commission for Technology and Innovation - CTI | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData